|
|
|
|
| LEADER |
01636nam a2200325 u 4500 |
| 001 |
EB001897060 |
| 003 |
EBX01000000000000001060065 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
200523 r ||| eng |
| 100 |
1 |
|
|a Kim, Joanne
|
| 245 |
0 |
0 |
|a Interventions for the treatment of obstructive sleep apnea in adults
|h Elektronische Ressource
|b a health technology assessment
|c Joanne Kim [and 13 others]
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b CADTH
|c 2017, March 2017
|
| 300 |
|
|
|a 1 PDF file (566 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Positive-Pressure Respiration
|
| 653 |
|
|
|a Adult
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Sleep Apnea, Obstructive / therapy
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Patient Satisfaction
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH optimal use report
|
| 500 |
|
|
|a "PROSPERO registration number: CRD42016036348."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK535532
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The aim of this health technology assessment (HTA) was to assess the clinical effectiveness, cost-effectiveness, patient perspectives and experiences, ethical issues, implementation issues, and environmental impacts of positive airway pressure (PAP) devices, expiratory positive airway pressure (EPAP) valves, oral appliances (OAs), surgery, and lifestyle modifications for the treatment of OSA in adults
|